Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 10.00
0.00 (0.00%)
At close: Feb 9, 2026
Devonian Health Group Employees
As of July 31, 2025, Devonian Health Group had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
1.85M CAD
Profits / Employee
-696.53K CAD
Market Cap
27.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2025 | 11 | 3 | 37.50% | 8 | 3 |
| Jul 31, 2024 | 8 | 1 | 14.29% | 6 | 2 |
| Jul 31, 2023 | 7 | - | - | 6 | 1 |
| Jan 31, 2017 | 5 | - | - | 5 | 0 |
| Oct 31, 2016 | 5 | - | - | 5 | 0 |
Devonian Health Group News
- 2 months ago - Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update - Benzinga
- 8 months ago - Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy - IBTimes
- 10 months ago - Devonian Health Group Announces Reinstatement of Quotation on the TSXV - Financial Post
- 1 year ago - Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis - Financial Post
- 1 year ago - Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine™ for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Financial Post
- 1 year ago - Devonian Health Group Inc. Reports Superior Anti-Inflammatory Potency of Thykamine™ in Comparative In Vitro Study - Financial Post